Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inIOncology

Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer

Posted by By Mourabit Halima 2025.07.01Posted inIOncology0 Shares
Home » Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer
YouTube player
Post Views: 5,638

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2025.07.01
Mourabit Halima
View All Posts

Post navigation

Previous Post
New Practices in Precision Tumor Immunotherapy New Practices in Precision Tumor Immunotherapy
Next Post
Progress and Challenges of Novel Immunotherapy Targets Progress and Challenges of Novel Immunotherapy Targets
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
Media Medic Publishing Company Limited(HK)
赛美出版有限公司（香港）
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied